JPS649978A - Perfluoroalkylisoxazole derivative - Google Patents

Perfluoroalkylisoxazole derivative

Info

Publication number
JPS649978A
JPS649978A JP16758787A JP16758787A JPS649978A JP S649978 A JPS649978 A JP S649978A JP 16758787 A JP16758787 A JP 16758787A JP 16758787 A JP16758787 A JP 16758787A JP S649978 A JPS649978 A JP S649978A
Authority
JP
Japan
Prior art keywords
alkyl
formula
compound shown
halogen
perfluoroalkylisoxazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP16758787A
Other languages
Japanese (ja)
Inventor
Shinzaburo Sumimoto
Ichiro Ishizuka
Shiro Ueda
Akira Takase
Katsuto Okuno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Priority to JP16758787A priority Critical patent/JPS649978A/en
Publication of JPS649978A publication Critical patent/JPS649978A/en
Pending legal-status Critical Current

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

NEW MATERIAL:A compound shown by formula I {RF is 1-3C perfluoroalkyl; X is H, halogen, 1-4C alkyl or phenyl which may contain substituent group (halogen or methyl); A is group shown by formula II formula IV [R<1> and R<2> are H, alkyl or acyl; R<3> is H or alkyl; R<4> is alkyl, alkenyl or alkoxy; R<5> is H, alkyl or alkenyl; X<1> and X<2> are H, halogen, OH, CH or alkyl; Y1-Y2 are (CH2)n (n is 2 or 3), CH2CH(OZ<1>) or COCH(OZ<2>) (Z<1> and Z<2> are H or alkyl)]}. EXAMPLE:1-Methyl-1-n-butyl-3-(3-trifluoromethyl-5-isoxazolyl)urea. USE:A herbicide or a fungicide. PREPARATION:For example, a compound shown by formula V is reacted with a compound shown by formula RFCO2R<6> (R<6> is alkyl) to give a compound shown by formula I wherein X is H and A is group shown by formula III (R<2> is H).
JP16758787A 1987-07-02 1987-07-02 Perfluoroalkylisoxazole derivative Pending JPS649978A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP16758787A JPS649978A (en) 1987-07-02 1987-07-02 Perfluoroalkylisoxazole derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16758787A JPS649978A (en) 1987-07-02 1987-07-02 Perfluoroalkylisoxazole derivative

Publications (1)

Publication Number Publication Date
JPS649978A true JPS649978A (en) 1989-01-13

Family

ID=15852520

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16758787A Pending JPS649978A (en) 1987-07-02 1987-07-02 Perfluoroalkylisoxazole derivative

Country Status (1)

Country Link
JP (1) JPS649978A (en)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6225323B1 (en) * 1997-04-10 2001-05-01 Joseph Koziak Activated iododerivatives for the treatment of cancer and AIDS
US6511988B2 (en) * 1997-04-10 2003-01-28 Isotechnika Inc. Activated iododerivatives for the treatment of cancer and aids
US20080139634A2 (en) * 2006-03-29 2008-06-12 Regents Of The University Of California Diarylthiohydantoin compounds
EP2004181A4 (en) * 2006-03-27 2010-11-10 Univ California ANDROGEN RECEPTOR MODULATOR FOR THE TREATMENT OF PROSTATE CANCER AND ANDROGEN RECEPTOR RELATED DISEASES
JP2012526820A (en) * 2009-05-12 2012-11-01 ロマーク ラボラトリーズ エル．シー． Haloalkylheteroarylbenzamide compounds
WO2013087577A1 (en) 2011-12-13 2013-06-20 Bayer Intellectual Property Gmbh N-(1,2,5-oxadiazol-3-yl), n-(1,3,4-oxadiazol-2-yl), n-(tetrazol-5-yl), and n-(triazol-5-yl) aryl carboxylic acid amides and use thereof as herbicides
JP2013536817A (en) * 2010-09-01 2013-09-26 バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー N- (tetrazol-5-yl) arylcarboxamides and N- (triazol-5-yl) arylcarboxamides and their use as herbicides
WO2014086746A1 (en) * 2012-12-07 2014-06-12 Bayer Cropscience Ag N-(isoxazol-3-yl)-aryl-carboxylic acid amides and use thereof as herbicides
WO2014086734A1 (en) * 2012-12-06 2014-06-12 Bayer Cropscience Ag N-(oxazol-2-yl)-aryl-carboxylic acid amides and use thereof as herbicides
JP2014521676A (en) * 2011-08-03 2014-08-28 バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー N- (tetrazol-5-yl) arylcarboxamides and N- (triazol-5-yl) arylcarboxamides and their use as herbicides
US9023877B2 (en) 2009-06-26 2015-05-05 Romark Laboratories L.C. Compounds and methods for treating influenza
AU2013205325B2 (en) * 2006-03-27 2016-03-24 The Regents Of The University Of California Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
WO2016071361A3 (en) * 2014-11-07 2016-06-23 Syngenta Participations Ag Herbicidal compounds
AU2016201061B2 (en) * 2006-03-27 2017-03-02 The Regents Of The University Of California Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
US10023556B2 (en) 2010-02-16 2018-07-17 Aragon Pharmaceuticals, Inc. Androgen receptor modulators and uses thereof
US10071095B2 (en) 2009-05-12 2018-09-11 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of neurological and psychiatric disorders
US10501469B2 (en) 2016-01-11 2019-12-10 Janssen Pharmaceutica Nv Substituted thiohydantoin derivatives as androgen receptor antagonists
US10702508B2 (en) 2017-10-16 2020-07-07 Aragon Pharmaceuticals, Inc. Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer
US10799488B2 (en) 2012-09-26 2020-10-13 Aragon Pharmaceuticals, Inc. Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer

Cited By (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6225323B1 (en) * 1997-04-10 2001-05-01 Joseph Koziak Activated iododerivatives for the treatment of cancer and AIDS
US6511988B2 (en) * 1997-04-10 2003-01-28 Isotechnika Inc. Activated iododerivatives for the treatment of cancer and aids
AU2017203683B2 (en) * 2006-03-27 2018-07-05 The Regents Of The University Of California Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
EP2656842A3 (en) * 2006-03-27 2014-04-02 The Regents of The University of California Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
AU2013205325B2 (en) * 2006-03-27 2016-03-24 The Regents Of The University Of California Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
AU2007243651B2 (en) * 2006-03-27 2012-08-30 The Regents Of The University Of California Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
AU2016201061B2 (en) * 2006-03-27 2017-03-02 The Regents Of The University Of California Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
AU2007243651C1 (en) * 2006-03-27 2013-03-14 The Regents Of The University Of California Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
US8445507B2 (en) 2006-03-27 2013-05-21 The Regents Of The University Of California Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
US11771687B2 (en) 2006-03-27 2023-10-03 The Regents Of The University Of California Substituted diazaspiroalkanes as androgen receptor modulators
US9987261B2 (en) 2006-03-27 2018-06-05 The Regents Of The University Of California Substituted diazaspiroalkanes as androgen receptor modulators
EP2004181A4 (en) * 2006-03-27 2010-11-10 Univ California ANDROGEN RECEPTOR MODULATOR FOR THE TREATMENT OF PROSTATE CANCER AND ANDROGEN RECEPTOR RELATED DISEASES
US8802689B2 (en) 2006-03-27 2014-08-12 The Regents Of The University Of California Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
US20080139634A2 (en) * 2006-03-29 2008-06-12 Regents Of The University Of California Diarylthiohydantoin compounds
US8110594B2 (en) * 2006-03-29 2012-02-07 The Regents Of The University Of California Diarylthiohydantoin compounds
US10071095B2 (en) 2009-05-12 2018-09-11 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of neurological and psychiatric disorders
US9126992B2 (en) 2009-05-12 2015-09-08 Romark Laboratories, L.C. Haloalkyl heteroaryl benzamide compounds
USRE47786E1 (en) 2009-05-12 2019-12-31 Romark Laboratories L.C. Haloalkyl heteroaryl benzamide compounds
US8846727B2 (en) 2009-05-12 2014-09-30 Romark Laboratories, L.C. Haloalkyl heteroaryl benzamide compounds
USRE46724E1 (en) 2009-05-12 2018-02-20 Romark Laboratories, L.C. Haloalkyl heteroaryl benzamide compounds
JP2012526820A (en) * 2009-05-12 2012-11-01 ロマーク ラボラトリーズ エル．シー． Haloalkylheteroarylbenzamide compounds
US10363243B2 (en) 2009-06-26 2019-07-30 Romark Laboratories L.C. Compounds and methods for treating influenza
US9820975B2 (en) 2009-06-26 2017-11-21 Romark Laboratories L.C. Compounds and methods for treating influenza
US11850237B2 (en) 2009-06-26 2023-12-26 Romark Laboratories L.C. Compounds and methods for treating influenza
US10912768B2 (en) 2009-06-26 2021-02-09 Romark Laboratories L.C. Compounds and methods for treating influenza
US9345690B2 (en) 2009-06-26 2016-05-24 Romark Laboratories L.C. Compounds and methods for treating influenza
US9023877B2 (en) 2009-06-26 2015-05-05 Romark Laboratories L.C. Compounds and methods for treating influenza
US10023556B2 (en) 2010-02-16 2018-07-17 Aragon Pharmaceuticals, Inc. Androgen receptor modulators and uses thereof
JP2013536817A (en) * 2010-09-01 2013-09-26 バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー N- (tetrazol-5-yl) arylcarboxamides and N- (triazol-5-yl) arylcarboxamides and their use as herbicides
JP2014521676A (en) * 2011-08-03 2014-08-28 バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー N- (tetrazol-5-yl) arylcarboxamides and N- (triazol-5-yl) arylcarboxamides and their use as herbicides
WO2013087577A1 (en) 2011-12-13 2013-06-20 Bayer Intellectual Property Gmbh N-(1,2,5-oxadiazol-3-yl), n-(1,3,4-oxadiazol-2-yl), n-(tetrazol-5-yl), and n-(triazol-5-yl) aryl carboxylic acid amides and use thereof as herbicides
JP2015505849A (en) * 2011-12-13 2015-02-26 バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー N- (1,2,5-oxadiazol-3-yl)-, N- (1,3,4-oxadiazol-2-yl)-, N- (tetrazol-5-yl)-, and N- (Triazol-5-yl) arylcarboxylic amides and their use as herbicides
CN103987701A (en) * 2011-12-13 2014-08-13 拜耳知识产权有限责任公司 N-(1,2,5-oxadiazol-3-yl), N-(1,3,4-oxadiazol-2-yl), N-(tetrazol-5-yl), and N-(triazol-5-yl) aryl carboxylic acid amides and use thereof as herbicides
US10849888B2 (en) 2012-09-26 2020-12-01 Aragon Pharmaceuticals, Inc. Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
USRE49353E1 (en) 2012-09-26 2023-01-03 Aragon Pharmaceuticals, Inc. Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
USRE50642E1 (en) 2012-09-26 2025-10-21 Aragon Pharmaceuticals, Inc. Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
US10799488B2 (en) 2012-09-26 2020-10-13 Aragon Pharmaceuticals, Inc. Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
US10799489B2 (en) 2012-09-26 2020-10-13 Aragon Pharmaceuticals, Inc. Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
WO2014086734A1 (en) * 2012-12-06 2014-06-12 Bayer Cropscience Ag N-(oxazol-2-yl)-aryl-carboxylic acid amides and use thereof as herbicides
JP2016502547A (en) * 2012-12-06 2016-01-28 バイエル・クロップサイエンス・アクチェンゲゼルシャフト N- (oxazol-2-yl) -aryl-carboxylic acid amides and their use as herbicides
US9758494B2 (en) 2012-12-06 2017-09-12 Bayer Cropscience Ag N-(oxazol-2-yl)-aryl-carboxylic acid amides and use thereof as herbicides
CN104854104A (en) * 2012-12-06 2015-08-19 拜尔农作物科学股份公司 N-(oxazol-2-yl)-aryl-carboxylic acid amides and their use as herbicides
WO2014086746A1 (en) * 2012-12-07 2014-06-12 Bayer Cropscience Ag N-(isoxazol-3-yl)-aryl-carboxylic acid amides and use thereof as herbicides
JP2016506385A (en) * 2012-12-07 2016-03-03 バイエル・クロップサイエンス・アクチェンゲゼルシャフト N- (isoxazol-3-yl) -aryl-carboxylic acid amides and their use as herbicides
WO2016071361A3 (en) * 2014-11-07 2016-06-23 Syngenta Participations Ag Herbicidal compounds
US10501469B2 (en) 2016-01-11 2019-12-10 Janssen Pharmaceutica Nv Substituted thiohydantoin derivatives as androgen receptor antagonists
US10981926B2 (en) 2016-01-11 2021-04-20 Janssen Pharmaceutica Nv Substituted thiohydantoin derivatives as androgen receptor antagonists
US11491149B2 (en) 2017-10-16 2022-11-08 Aragon Pharmaceuticals, Inc. Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer
US11160796B2 (en) 2017-10-16 2021-11-02 Aragon Pharmaceuticals, Inc. Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer
US10702508B2 (en) 2017-10-16 2020-07-07 Aragon Pharmaceuticals, Inc. Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer

Similar Documents

Publication Publication Date Title
JPS649978A (en) Perfluoroalkylisoxazole derivative
JPS6479184A (en) Pyrazolotriazine derivative
JPS6425763A (en) Pyrazoles and insecticide and acaricide containing said pyrazoles as active ingredient
ES8800246A1 (en) Pesticidal silylmethyl ether compounds.
AU5117890A (en) Trifluromethylphenylazolylmethyloxiranes, the preparation thereof and the use thereof as crop protection agents
HUT54350A (en) Insecticidal and nematocidal plant protective compositions, process for producing veterinary compositions suitable for killing helminths and protozoa, as well as process for producing 1-arylimidazoles used as active ingredient
AU8047587A (en) Insecticidal thioethers and derivatives thereof
EP1468693A3 (en) Use of 2,6-di -alkyl-4-silyl-phenols for treating diabetes mellitus
DK0508740T3 (en) Thiazolidinedione derivatives, their preparation and use.
IE781962L (en) Phenyl isothiocyanate derivatives
FI881104A0 (en) Process for the preparation of benzoxazine derivatives for use as antidiabetic agents
GB2164936B (en) Pesticidal substituted carbodiimides
JPS5653662A (en) Preparation of delta2-1,2,4-triazolin-5-ones
HUT51603A (en) Herbicide and plant growth regulating preparation containing alkyl- and alkenyl-sulfonyl-urea compounds substituted by heterocyclic radical as well as process for producing the active agents
TW350757B (en) Benzisoxazole derivatives and pesticidal compositions containing them
EP0235567A3 (en) Indazole compounds, their production, use and intermediates
JPS57183764A (en) Substituted acetanilide compound, its preparation, and herbicide
JPS56154427A (en) Novel 2-phenylpropyl ether derivative, its preparation and insecticide and miticide with low toxicity to fish containing the same
JPS5716867A (en) Pyrazole derivative and herabicide containing the same as active principle
EP0194064A3 (en) Azolyl substituted aralkyl compounds
JPS6429369A (en) Oxazoline derivative
JPS5746943A (en) Preparation of cyclohexane derivative
JPS56164161A (en) Preparation of 2-cyclohexene-1-one derivative
JPS57209274A (en) Urea derivative, its preparation and its use
JPS6452771A (en) Amino-containing 1,3-dithian compound and insecticidal and acaricidal composition containing said compound